1 |
American Diabetes association. Postprandial blood glucose. Diabetes Care 24:775-778, 2001
DOI
PUBMED
ScienceOn
|
2 |
Giancaaterini A, De Gaetano A, Mingrone G, Capristo E, Greco A. Acetyl-L-carnitine infusion increases glucose disposal in type 2 diabetic patients. Metabolism 49:704-708, 2000
DOI
ScienceOn
|
3 |
Lowitt S, Malone J, Salem A, Korthals J, Benford S. Acetyl L-carnitine corrects the altered peripheral nerve function of experimental diabetes. Metabolism 44:677-680, 1995
DOI
ScienceOn
|
4 |
Heo Y, Lee Y, Cha Y. L-carnitine Administration Improves Lipid Metabolism in Streptozotocin-induced diabetic rat. Nutritional Science 5:3-8, 2002
|
5 |
Cavallero E, Dachet C, Neufcou D, Wirquin E, Mathe D, Jacotot B. Postprandial amplication of lipopotein abnormalities in controlled type II diabetic subjects: relationship to postprandial lipemia and C-peptide/glucagons levels. Metabolism 43:270-278, 1994
DOI
ScienceOn
|
6 |
Derosa G, Cicero A, Gaddi A, Mugellini A, Ciccarelli L, Fogari R. The effect of L-carnitine on plasma lipoprotein(a) levels in hypercholesterolemic patients with type 2 diabetes mellitus. Clin Ther 25:1429-1439, 2003
DOI
ScienceOn
|
7 |
Reaven G. Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
DOI
PUBMED
ScienceOn
|
8 |
Sachan D, Dodsan W. The serum carnitine status of cancer patients. J Am Nutr 6(2):14-15, 1987
|
9 |
Gulli G, Ferrannini E, Stern M, Haffner S, DeFronzo R. The metabolic profile of NIDDM is fully established in glucosetolerant offsprings of two Mexican-American NIDDM parents. Diabetes 41:1575-1586, 1992
DOI
ScienceOn
|
10 |
Matthai S, Stmvoll M, Kellerer M, Haring H. Pathophysiology and pharmacological treatment of insulin resistance. Endocr Rev 21:585-618, 2000
DOI
ScienceOn
|
11 |
Niina M, Mikko S, Marja-riitta T. Postprandial lipid metabolism in diabetes. Atherosclerosis 141suppl:S53-S55, 1998
DOI
ScienceOn
|
12 |
Bieber L. Carnitine. AnnRev Biochem 57:261-283, 1988
DOI
PUBMED
ScienceOn
|
13 |
Brooks S, Bahl J, Bressler R. Carnitine in the streptozotocin-diabetic rat. J Nutr 115:1267-1273, 1985
DOI
|
14 |
Yoshikawa Y, Ueda E, Sahurai H, Kojima Y. Anti-diabetices effect of Zn(II)/carnitine complex by oral administration. Chem Pharm Bull 51:230-231, 2003
DOI
ScienceOn
|
15 |
Monola P, Belfiore A, Santangelo F, Senicchio M. L-Carnitine on the apolipoprotein pattern of rats fed a cholesterol-rich diet. Comp Biochem Physiol 89:69-73, 1988
DOI
ScienceOn
|
16 |
Rebouche C, Seim H. Carnitine metabolism and its regulation in microorganisms and mammals. Annu Rev Nutr 8:39-61, 1998
|
17 |
Lillioja S, Mott D, Howard B, Bennett P, Yki-Jarvinen H, Freymond D, Nyomba B, Zurlo F, Swinburn B, Bogardus C. Impaired glucose tolerance as a disorder of insulin action: longitudinal and cross-sectional studies in Pima Indians. N Engl J Med 318:1217-1225, 1988
DOI
ScienceOn
|
18 |
Weyer C, Bogardus C, Mott D, Pratley R. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 104:787-794, 1999
DOI
ScienceOn
|
19 |
Laakso M. Hyperglycemia and cardiovascular disease in Type 2 diabetes. Diabetes 48:937-942, 1999
DOI
PUBMED
ScienceOn
|
20 |
DeFronzo R. Pathogenesis of type 2 diabetes; metabolic and molecular implications for identifying diabetes genes. Diabetes Reviews 5:177-269, 1997
|
21 |
Howard B. Lipoprotein metabolism in diabetes mellitus. J Lipid Res 28:613-628, 1987
|
22 |
Kendler B. Carnitine. An overview if its role in preventive medicine. Preventive Medicine 15:373-390, 1986
DOI
PUBMED
ScienceOn
|
23 |
Martin B, Warram J, Krolewski A, Bergman R, Soeldner J, Kahn C. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 340:925-929, 1992
DOI
ScienceOn
|
24 |
DeFronzo R, Bonadonna R, Ferrannini E. Pathogenesis of NIDDM: a balanced overview. Diabetes Care 15:318-368, 1992
DOI
ScienceOn
|
25 |
Bell F, Vidmar R, Raymond T. L-carnitine administration and withdrawal affect plasma and hepatic carnitine concentrations, plasma lipid and lipoprotein composition, and in vitro hepatic lipogenesis from labeled mevalonate and olate in normal rabits. J Nutr 122:959-966, 1992
DOI
|